Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer
Authors
Keywords
-
Journal
Molecular Oncology
Volume 11, Issue 10, Pages 1413-1429
Publisher
Wiley
Online
2017-07-04
DOI
10.1002/1878-0261.12108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- More deaths from pancreatic cancer than breast cancer in the EU by 2017
- (2016) J. Ferlay et al. ACTA ONCOLOGICA
- Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer
- (2016) Barbara Burtness et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme
- (2016) İlhan Elmaci et al. BIOCHEMICAL GENETICS
- Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study
- (2016) E. J. Childs et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
- (2016) Erik S. Knudsen et al. GASTROENTEROLOGY
- Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
- (2016) Archana Bhaw-Luximon et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pancreatic cancer
- (2016) Terumi Kamisawa et al. LANCET
- Phase I study of olaparib plus gemcitabine in patients with advanced solid tumours and comparison with gemcitabine alone in patients with locally advanced/metastatic pancreatic cancer
- (2015) J. Bendell et al. ANNALS OF ONCOLOGY
- Identification of germline genetic mutations in patients with pancreatic cancer
- (2015) Erin E. Salo-Mullen et al. CANCER
- Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial
- (2015) L. A. Chantrill et al. CLINICAL CANCER RESEARCH
- Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer
- (2015) Hisato Kawakami et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
- (2015) GEORGE MIHAI NITULESCU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- High burden and pervasive positive selection of somatic mutations in normal human skin
- (2015) I. Martincorena et al. SCIENCE
- Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
- (2015) Agnieszka K. Witkiewicz et al. Nature Communications
- Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
- (2015) E. Gabriela Chiorean et al. Drug Design Development and Therapy
- Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer
- (2015) Agnieszka K. Witkiewicz et al. Oncotarget
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
- (2015) Bianca Cheaib et al. Chinese Journal of Cancer
- Aurora Kinase Inhibitors: Current Status and Outlook
- (2015) Vassilios Bavetsias et al. Frontiers in Oncology
- FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
- (2014) Aziz Zaanan et al. BMC CANCER
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The changing landscape of phase II/III metastatic NSCLC clinical trials and the importance of biomarker selection criteria
- (2014) Ryan D. Gentzler et al. CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Personalized Medicine for Patients with Advanced Cancer in the Phase I Program at MD Anderson: Validation and Landmark Analyses
- (2014) A.-M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- Exploiting APC Function as a Novel Cancer Therapy
- (2014) Alyssa Lesko et al. CURRENT DRUG TARGETS
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs
- (2014) Mark G. Kris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pancreatic Adenocarcinoma: Treating a Systemic Disease With Systemic Therapy
- (2014) D. P. Sohal et al. JNCI-Journal of the National Cancer Institute
- Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer
- (2014) Youngchul Kim et al. PLoS One
- Pancreatic cancer should be treated as a medical emergency
- (2014) J.-M. Lohr BMJ-British Medical Journal
- Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
- (2014) Dana B. Cardin et al. Cancer Medicine
- Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms
- (2013) Geneva Young et al. CANCER CYTOPATHOLOGY
- Clinical Applications of Next-Generation Sequencing: The 2013 Human Genome Variation Society Scientific Meeting
- (2013) Sian Ellard et al. HUMAN MUTATION
- The economic evaluation of personalised oncology medicines: ethical challenges
- (2013) Jan R R Lewis et al. MEDICAL JOURNAL OF AUSTRALIA
- Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells
- (2013) Pinghua Hu et al. MOLECULAR BIOLOGY REPORTS
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and molecular characterization of HER2 amplified-pancreatic cancer
- (2013) Angela Chou et al. Genome Medicine
- Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) T. Seufferlein et al. ANNALS OF ONCOLOGY
- Is Personalization of Care Coming to Pancreatic Oncology?
- (2012) Christopher H. Crane ANNALS OF SURGICAL ONCOLOGY
- Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure
- (2012) Hielke J. Meulenbeld et al. BJU INTERNATIONAL
- Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
- (2012) J Harder et al. BRITISH JOURNAL OF CANCER
- Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge
- (2012) Sau Wai Hung et al. CANCER LETTERS
- Pharmacogenomics Knowledge for Personalized Medicine
- (2012) M Whirl-Carrillo et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
- (2012) Ross A. Soo et al. CURRENT DRUG TARGETS
- Current concepts and novel targets in advanced pancreatic cancer
- (2012) Patrick Michl et al. GUT
- Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid
- (2012) Patrick Michl et al. GUT
- Applying next-generation sequencing to pancreatic cancer treatment
- (2012) Elaine R. Mardis Nature Reviews Gastroenterology & Hepatology
- Deep Clonal Profiling of Formalin Fixed Paraffin Embedded Clinical Samples
- (2012) Tara Holley et al. PLoS One
- Pancreatic adenocarcinoma
- (2012) G. Bond-Smith et al. BMJ-British Medical Journal
- Genetic Variations in Multiple Drug Action Pathways and Survival in Advanced Stage Non-Small Cell Lung Cancer Treated with Chemotherapy
- (2011) Y. Li et al. CLINICAL CANCER RESEARCH
- Metastatic pancreatic cancer: old drugs, new paradigms
- (2011) Thierry Conroy et al. CURRENT OPINION IN ONCOLOGY
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Emerging Entity: Pancreatic Adenocarcinoma Associated with a Known BRCA Mutation: Clinical Descriptors, Treatment Implications, and Future Directions
- (2011) M. A. Lowery et al. ONCOLOGIST
- Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer
- (2010) Howard Safran et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer
- (2010) Allan Lipton et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Pancreatic cancer: understanding and overcoming chemoresistance
- (2010) Zhiwei Wang et al. Nature Reviews Gastroenterology & Hepatology
- Pharmacogenomics and bioinformatics: PharmGKB
- (2010) Caroline F Thorn et al. PHARMACOGENOMICS
- Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors
- (2009) Neeltje Steeghs et al. JOURNAL OF CLINICAL ONCOLOGY
- The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model
- (2009) E. C. VanderPorten et al. MOLECULAR CANCER THERAPEUTICS
- Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
- (2009) Maria S. Pino et al. ONCOLOGY
- The Human Gene Mutation Database: 2008 update
- (2009) Peter D Stenson et al. Genome Medicine
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started